RICE HALL JAMES & ASSOCIATES, LLC - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 1 filers reported holding ANTARES PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
RICE HALL JAMES & ASSOCIATES, LLC ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2022$4,997,000
+15.5%
1,218,851
+0.6%
0.20%
+29.2%
Q4 2021$4,325,000
+75.6%
1,211,351
+79.0%
0.15%
+69.2%
Q3 2021$2,463,000
-16.8%
676,687
-0.3%
0.09%
-13.3%
Q2 2021$2,959,000
+2.6%
678,683
-3.3%
0.10%
+11.7%
Q1 2021$2,883,000
+20.5%
701,499
+17.0%
0.09%
+11.9%
Q4 2020$2,393,000599,6280.08%
Other shareholders
ANTARES PHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 500,000$2,180,0004.34%
FIRST WILSHIRE SECURITIES MANAGEMENT INC 2,535,727$11,056,0003.87%
Sargent Investment Group, LLC 3,596,250$15,680,0003.72%
Rubric Capital Management LP 9,500,000$41,420,0002.61%
PERKINS CAPITAL MANAGEMENT INC 541,783$2,362,0001.34%
ORACLE INVESTMENT MANAGEMENT INC 1,900,000$8,284,0001.14%
Venator Capital Management Ltd. 709,700$3,094,0001.05%
LEVEL FOUR FINANCIAL, LLC 120,000$523,0000.22%
OBERWEIS ASSET MANAGEMENT INC/ 200,600$875,0000.19%
Brown Advisory Securities, LLC 275,000$1,199,0000.19%
View complete list of ANTARES PHARMA INC shareholders